NACDS signed on to a letter supporting the Restoring Access to Medications Act, which would allow Americans to use the funds in their healthcare accounts to purchase over-the-counter (OTC) medications.
A poll of registered voters, conducted by Morning Consult and commissioned by NACDS, includes findings that can help make the case for direct and indirect remuneration (DIR) fee relief, and for broader reimbursement issues.
Former Speaker of the House of Representatives Paul Ryan (R-WI), Pulitzer Prize-winning author Doris Kearns Goodwin and Former Senator Jeff Flake (R-AZ) are set to speak at the 2019 NACDS Annual Meeting, April 27-30.
Rep. Ami Bera (D-CA) recognized the importance of pharmacists as accessible healthcare providers during a Costco pharmacy tour as part of the NACDS RxIMPACT program.
NACDS Senior Vice President and General Counsel Don Bell was recently named the only association general counsel to the "GC Powerlist" by The Legal 500.
Members of Congress reported to their constituents on meetings they had during NACDS RxIMPACT Day on Capitol Hill on opioid abuse prevention and DIR fee reform.
"On social media, we saw a photo of NACDS Board of Directors member Richard Ashworth, president, operations, Walgreen Co., at a white board in the office of U.S. Sen. Bill Cassidy (R-LA), literally drawing out an example for the Senator that demonstrates the need for fair pharmacy reimbursement, for transparency in the prescription drug supply chain, and for appropriate pharmacy metrics that should be tethered to DIR fee reform."
Americans for Free Trade, a broad coalition united against tariffs, of which NACDS is a member, sent a letter this week to President Trump commending the administration for delaying an upcoming tariff hike.
Inside–the–Beltway publications will send a strong message next week: Pharmacy stands as a trusted source of cost–reducing policy strategies, and DIR fee reform tops the agenda.